September 20, 2019
Stakeholder Letter to DEA on Ryan Haight Special Registration
FOR YOU:
Stakeholder Letter to DEA on Ryan Haight Special Registration
ATA, along with a number of healthcare stakeholders, submitted a letter with comments on the Drug Enforcement Administration’s (DEA) implementation of a Special Registration provision for telemedicine under the Ryan Haight Act.